John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$510M |
| 2 |
Broadcom
AVGO
|
+$318M |
| 3 |
Marvell Technology
MRVL
|
+$290M |
| 4 |
Salesforce
CRM
|
+$263M |
| 5 |
Advanced Micro Devices
AMD
|
+$250M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$255M |
| 2 |
Progressive
PGR
|
+$244M |
| 3 |
Visa
V
|
+$238M |
| 4 |
Lam Research
LRCX
|
+$201M |
| 5 |
Elevance Health
ELV
|
+$190M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.88% |
| 2 | Healthcare | 13.28% |
| 3 | Financials | 10.32% |
| 4 | Industrials | 9.79% |
| 5 | Consumer Discretionary | 8.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Repligen
RGEN
$10.2B
| $28.7M | 0.06% |
225,306
-133,733
| -37% | -$20.6M |
|
|
ONC
352
BeOne Medicines Ltd
ONC
$42.4B
| $28.4M | 0.06% |
+104,466
| New | +$24.4M |
|
353
Vanguard Dividend Appreciation ETF
VIG
$114B
| $28.4M | 0.06% |
146,403
-55,800
| -28% | -$11.1M |
|
354
TAL Education Group
TAL
$6.28B
| $28.3M | 0.06% |
+2,144,766
| New | +$26.7M |
|
355
Sherwin-Williams
SHW
$84.1B
| $28.3M | 0.06% |
81,010
+33,235
| +70% | +$11.7M |
|
356
WEX
WEX
$6.81B
| $28.1M | 0.06% |
179,261
+178,034
| +14,510% | +$29.3M |
|
357
ZIM Integrated Shipping Services
ZIM
$3.4B
| $28.1M | 0.06% |
1,926,709
-647,838
| -25% | -$12.2M |
|
358
Ciena
CIEN
$56B
| $28.1M | 0.06% |
465,064
+422,667
| +997% | +$33.4M |
|
359
Procept Biorobotics
PRCT
$1.24B
| $28M | 0.06% |
480,691
+126,975
| +36% | +$8.67M |
|
360
Upwork
UPWK
$1.08B
| $27.7M | 0.06% |
2,122,070
-314,610
| -13% | -$4.79M |
|
361
YPF Sociedad Anonima ADS
YPF
$20.1B
| $27.6M | 0.06% |
788,280
-195,621
| -20% | -$7.49M |
|
362
iShares US Broker-Dealers & Securities Exchanges ETF
IAI
$1.41B
| $27.6M | 0.06% |
196,900
+169,500
| +619% | +$25.2M |
|
363
Sweetgreen
SG
$832M
| $27.3M | 0.06% |
1,092,380
+339,136
| +45% | +$9.36M |
|
|
ARES.PRB
364
Ares Management Corp 6.75% Series B Preferred Stock
ARES.PRB
$1.35B
| $27.2M | 0.06% |
564,938
+557,124
| +7,130% | +$30.3M |
|
365
Legend Biotech
LEGN
$4.24B
| $27.2M | 0.06% |
801,781
+159,329
| +25% | +$5.71M |
|
366
Automatic Data Processing
ADP
$112B
| $27.2M | 0.06% |
88,992
-53,470
| -38% | -$16.1M |
|
367
Rubrik
RBRK
$20.6B
| $27.2M | 0.06% |
445,535
-203,814
| -31% | -$13.9M |
|
368
Tyler Technologies
TYL
$14.4B
| $27M | 0.06% |
46,460
+43,097
| +1,282% | +$25.6M |
|
369
Kinross Gold
KGC
$38.9B
| $27M | 0.06% |
2,138,996
-4,338,318
| -67% | -$48.7M |
|
370
Astera Labs
ALAB
$49.4B
| $26.9M | 0.06% |
450,114
-28,874
| -6% | -$2.67M |
|
371
Westlake Corp
WLK
$10.1B
| $26.6M | 0.06% |
266,071
+161,751
| +155% | +$17.9M |
|
372
Expeditors International
EXPD
$24.4B
| $26.6M | 0.06% |
221,247
-348,720
| -61% | -$40.1M |
|
|
NEE.PRT
373
NextEra Energy 7.234% Corporate Units
NEE.PRT
$1.44B
| $26.6M | 0.06% |
583,853
-1,043,182
| -64% | -$46.9M |
|
374
PUT
MP Materials
MP
$10.7B
| $26.5M | 0.06% |
1,087,600
+83,200
| +8% | +$1.93M |
|
375
Okta
OKTA
$23.5B
| $26.5M | 0.06% |
+251,610
| New | +$24.6M |
|
Similar funds
John Overdeck's Q1 2025 Portfolio in Review
As of Q1 2025, John Overdeck held 3,617 positions worth $46.8B, up 2% from $45.9B the previous quarter. Its ten largest holdings account for 8.1% of the portfolio.
John Overdeck deployed $2.08B of net new capital in Q1 2025, opening 458 new positions and adding to 1,225 existing holdings. Its largest new stake was Advanced Micro Devices: 2,246,952 shares worth $231M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Eli Lilly, an estimated $255M trimmed.
- John Overdeck's largest Q1 2025 buy was Advanced Micro Devices: 2,246,952 shares worth $231M.
- John Overdeck added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $510M increase.
- John Overdeck's biggest Q1 2025 reduction was Eli Lilly, cutting an estimated $255M.
- John Overdeck fully exited Coinbase in Q1 2025, selling an estimated $45M.
- John Overdeck's ten largest holdings make up 8.1% of its $46.8B portfolio in Q1 2025.
- John Overdeck opened 458 new positions and closed 452 in Q1 2025.
- John Overdeck's portfolio value rose 2% quarter-over-quarter to $46.8B.
Based on Two Sigma Investments's 13F filing for Q1 2025, filed 15 May 2025.